SMKG yields 40816.33% · PFE yields 6.13%● Live data
📍 SMKG pulled ahead of the other in Year 1
Combined, SMKG + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SMKG + PFE for your $10,000?
Smart Card Marketing Systems Inc., doing business as PaymentActiveNetwork, operates as a fintech solutions provider that delivers a cloud-based EMV MPOS, and EPOS Host platform to issuing and acquiring banks, telecoms, and global enterprises. The company offers EmphasisPay that delivers advisory and technology solutions for payment acquirers and issuers; Mtickets.events that allows users to create an event or events and issue mobile tickets; Genorocity.com, a web publication portal and mobile platform that enables retailers, property managers, and event promoters; and Check21SAAS.com, a remote check deposit solution. It also provides VelocityMPOS, a customizable EMV MPOS solution for Retail or 'On the Go business'; and Articul8te.com for individuals and businesses to create and publish articles. In addition, the company offers advisory and product development services. Smart Card Marketing Systems Inc. has strategic partnership with Quotientica Pvt Ltd. to deliver an AI driven fraud detection system to banks and financial institutions. The company was founded in 2006 and is based in Wilmington, Delaware. Smart Card Marketing Systems Inc. is a former subsidiary of Performance Optician Software Corporation.
Full SMKG Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.